{"protocolSection":{"identificationModule":{"nctId":"NCT00747279","orgStudyIdInfo":{"id":"HSD001"},"organization":{"fullName":"Hospital Sao Domingos","class":"OTHER"},"briefTitle":"Comparison of Two Strategies for Glycemic Control in Acute Ischemic Stroke","officialTitle":"Comparison of Two Strategies for Glycemic Control in Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2008-09","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2007-06"},"studyFirstSubmitDate":"2008-09-04","studyFirstSubmitQcDate":"2008-09-04","studyFirstPostDateStruct":{"date":"2008-09-05","type":"ESTIMATED"},"lastUpdateSubmitDate":"2008-09-08","lastUpdatePostDateStruct":{"date":"2008-09-09","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"leadSponsor":{"name":"Hospital Sao Domingos","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The purpose of this prospective randomized controlled trial was to compare intensive insulin therapy with a carbohydrate restrictive strategy in patients with acute ischemic stroke evaluating the outcome through the Glasgow Outcome Scale Extended, hospital mortality and NIHSS during the ICU stay."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":70,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"1","type":"EXPERIMENTAL","description":"Carbohydrate restrictive strategy","interventionNames":["Other: Carbohydrate restrictive strategy"]},{"label":"2","type":"ACTIVE_COMPARATOR","description":"Intensive insulin therapy","interventionNames":["Drug: Intensive insulin therapy"]}],"interventions":[{"type":"OTHER","name":"Carbohydrate restrictive strategy","description":"Patients will receive intravenous hydration with a glucose free solution (Ringer III) and enteral nutritional formula containing 33.3% carbohydrates, 16.7% proteins and 50% lipids. These patients will receive regular insulin subcutaneously four times daily, aiming to maintain blood glucose levels at least below 180 mg/dl, and in stable patients, ideally below 150 mg/dl.","armGroupLabels":["1"]},{"type":"DRUG","name":"Intensive insulin therapy","description":"Continuous intravenous regular insulin infusion will be adjusted to maintain glycemic levels at least below 150 mg/dl, and, in stable patients and ideally, between 80 and 120 mg/dl. Patients will be submitted to capillary glycemic measurements every 2 hours. The insulin dose is adjusted according to an algorithm run by nurses and overseen by physicians. These patients will receive glucosaline (5% glucose + 0.9 NaCl) hydration and enteral nutrition with a formula containing 45% carbohydrates, 17% proteins and 38% lipids.","armGroupLabels":["2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Neurological outcome through the Glasgow Outcome Scale Extended","timeFrame":"At least 4 months after hospital discharge"}],"secondaryOutcomes":[{"measure":"NIHSS during ICU stay","timeFrame":"ICU stay"},{"measure":"Hospital mortality","timeFrame":"Hospital stay"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adult patients with acute ischemic stroke defined as: Abrupt onset of focal neurologic deficit\n* No evidence of intracranial hemorrhage at non-contrasted CT scan.\n\nExclusion Criteria:\n\n* Age below 18\n* Pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"JOSE R AZEVEDO, MD","role":"CONTACT","phone":"55 98 32275735","email":"jrazevedo@elo.com.br"}],"locations":[{"facility":"Hospital Sao Domingos","status":"RECRUITING","city":"Sao Luis","state":"MA","zip":"65060-642","country":"Brazil","contacts":[{"name":"JOSE R AZEVEDO, MD","role":"CONTACT","phone":"55 98 32275735","email":"jrazevedo@elo.com.br"},{"name":"JOSE R AZEVEDO, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":-2.52972,"lon":-44.30278}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000007328","term":"Insulin"}],"ancestors":[{"id":"D000007004","term":"Hypoglycemic Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"}],"browseLeaves":[{"id":"M10055","name":"Insulin","asFound":"Per","relevance":"HIGH"},{"id":"M173072","name":"Insulin, Globin Zinc","relevance":"LOW"},{"id":"M21550","name":"Pharmaceutical Solutions","relevance":"LOW"},{"id":"M4544","name":"Benzocaine","relevance":"LOW"},{"id":"M9744","name":"Hypoglycemic Agents","relevance":"LOW"},{"id":"T433","name":"Tannic Acid","relevance":"LOW"}],"browseBranches":[{"abbrev":"Hypo","name":"Hypoglycemic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"PhSol","name":"Pharmaceutical Solutions"},{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"Ot","name":"Other Dietary Supplements"}]}},"hasResults":false}